课题基金 / 基金详情

Inhibitors and Probes of HIV-1 Cell Fusion

Inhibitors and Probes of HIV-1 Cell Fusion
HIV-1 细胞融合的抑制剂和探针
批准号:
7967329
负责人:
Carole Bewley
金额:
$31.45万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Carole Bewley的其他基金

相似基金

相关文献

中文摘要
翻译
NIDDK的LBC天然产物化学部有几个正在进行的项目,其长期目标是鉴定和设计HIV-1包膜介导的细胞融合的抑制剂和探针。这些包括设计和开发具有抑制剂和免疫原双重功能的新的gp 41衍生肽和蛋白质,发现和高分辨率结构表征新的碳水化合物结合蛋白,其通过碳水化合物介导的与gp 120/gp 41的相互作用有效地抑制HIV-1进入,发现HIV-1融合的天然产物抑制剂,以及HIV-1包膜-辅助受体相互作用的结构和机制研究。
英文摘要
The Natural Products Chemistry Section, LBC, NIDDK has several ongoing projects whose long term aim is to identify and design inhibitors and probes of HIV-1 Envelope-mediated cell fusion. These include the design and development of new gp41-derived peptides and proteins that have dual functions as inhibitors and immunogens, discovery and high resolution structural characterization of new carbohydrate binding proteins that potently inhibit HIV-1 Entry through carbohydrate-mediated interactions with gp120/gp41, discovery of natural product inhibitors of HIV-1 fusion, and structural and mechanistic studies of HIV-1 Envelope - coreceptor interactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery of Natural Products and Natural Product-Like Inhibitors
NMR Facility Management and Application of NMR Spectroscopy
Discovery of Natural Products and Natural Product-Like Inhibitors
Inhibitors and Probes of HIV-1 Cell Fusion
海外基金